conjugated estrogens bazedoxifene
Selected indexed studies
- Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis. (Gynecol Endocrinol, 2022) [PMID:36036169]
- Management of Menopausal Symptoms: A Review. (JAMA, 2023) [PMID:36749328]
- Conjugated oestrogens/bazedoxifene. (Aust Prescr, 2017) [PMID:28798519]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Conjugated oestrogens/bazedoxifene. (2017) pubmed
- Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis. (2022) pubmed
- Management of Menopausal Symptoms: A Review. (2023) pubmed
- Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms. (2014) pubmed
- Conjugated Estrogens/Bazedoxifene (Duavee) for Menopausal Symptoms. (2016) pubmed
- Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention. (2012) pubmed
- Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women. (2015) pubmed
- Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review. (2012) pubmed
- Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis. (2007) pubmed
- Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. (2013) pubmed